Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial disorders.

A H Schapira1

  • 1University Department of Clinical Neurosciences, Royal Free and University College School of Medicine, and Institute of Neurology, University College London, UK. schapira@rfhsm.ac.uk

Current Opinion in Neurology
|November 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons.

Scientific reports·2018
Same author

Practical recommendations for the process of proposing, planning and writing a neurological management guideline by EAN task forces.

European journal of neurology·2015
Same author

The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2.

AJNR. American journal of neuroradiology·2014
Same author

The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 1.

AJNR. American journal of neuroradiology·2014
Same author

Early L-dopa, but not pramipexole, restores basal ganglia activity in partially 6-OHDA-lesioned rats.

Neurobiology of disease·2013
Same author

Colloidal gold staining and immunodetection in 2-d protein mapping.

Methods in molecular biology (Clifton, N.J.)·2012

Understanding of mitochondrial pathology is advancing rapidly. New genotype-phenotype correlations, disease models, and causes of secondary mitochondrial dysfunction are being identified, improving diagnosis and treatment strategies.

Area of Science:

  • Biochemistry
  • Genetics
  • Pathology

Background:

  • Mitochondrial diseases are a group of inherited metabolic disorders caused by mutations in mitochondrial DNA (mtDNA) or nuclear DNA.
  • These diseases can affect multiple organ systems and present with a wide range of clinical symptoms.
  • The understanding of mitochondrial pathology has been rapidly advancing, with new discoveries constantly emerging.

Purpose of the Study:

  • To review the latest advances in understanding mitochondrial pathology.
  • To highlight new genotype-phenotype correlations in mitochondrial DNA mutations.
  • To discuss emerging causes of secondary mitochondrial respiratory chain deficiency.

Main Methods:

  • Literature review of recent studies on mitochondrial pathology.

Related Experiment Videos

  • Analysis of genotype-phenotype correlations in mitochondrial DNA mutations.
  • Identification of new models for mitochondrial disease.
  • Review of drugs, toxins, and nuclear-encoded proteins affecting mitochondrial function.

    • Main Results:

    • Established new genotype-phenotype correlations, including exercise intolerance with cytochrome b mutations and early-onset multisystem disorders with cytochrome oxidase assembly defects.
    • Development of new models for studying mitochondrial diseases.
    • Recognition of drugs, toxins, and nuclear-encoded protein deficiencies as significant causes of secondary mitochondrial respiratory chain deficiency.

    Conclusions:

    • The field of mitochondrial pathology is rapidly evolving.
    • Advances in understanding genotype-phenotype correlations and disease mechanisms are crucial for diagnosis and treatment.
    • Secondary causes of mitochondrial dysfunction are increasingly recognized and important to consider.